Recent Androgen Receptor Antagonists in Prostate Cancer

被引：3

作者：

Lu, Xufang ^{[1
]}

Dun, Kang ^{[1
]}

Wang, Yang ^{[1
]}

Yang, Yong ^{[2
]}

You, Qidong ^{[1
]}

Li, Zhiyu ^{[1
]}

机构：

[1] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China

[2] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, State Key Lab Nat Med, Nanjing 210009, Peoples R China

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2014年 / 14卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Androgen receptor; castration-resistant prostate cancer; prostate cancer; BIOLOGICAL EVALUATION; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE AKR1C3; DESIGN; DERIVATIVES; INHIBITORS; DOMAIN; ACID;

D O I：

10.2174/1389557514666140622203207

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Androgen receptor has been shown to promote prostate cell growth and carcinogenesis of prostate cancer by up-regulating its target genes. Testosterone and dihydrotestosterone are two major hormones which bind to and activate androgen receptor. Targeting both the androgen receptor and the enzymes catalyzing the biosynthesis of testosterone and dihydrotestosterone has been shown to be clinically beneficial in the treatment of prostate cancer. Prostate cancer can become castration-resistant after long term treatment with chemo drugs, so efforts in finding compounds with improved efficiency to castration-resistant prostate cancer are urgently needed. In this review we summarized the studies on recent progress in the development of small molecular AR antagonists for the treatment of prostate cancer.

引用

页码：655 / 663

页数：9

共 50 条

[21] The androgen/androgen receptor axis in prostate cancer
Bluemn, Eric G.
Nelson, Peter S.
CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 251 - 257
[22] Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists
Joseph, James D.
Wittmann, Bryan M.
Dwyer, Mary A.
Cui, Huaxia
Dye, Delita A.
McDonnell, Donald P.
Norris, John D.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (29) : 12178 - 12183
[23] Development of Androgen Receptor Antagonists with Promising Activity in Castration-Resistant Prostate Cancer
Shen, Howard C.
Balk, Steven P.
CANCER CELL, 2009, 15 (06) : 461 - 463
[24] SAR Based Design of Nicotinamides as a Novel Class of Androgen Receptor Antagonists for Prostate Cancer
Yang, Su Hui
Song, Chin-Hee
Hue Thi My Van
Park, Eunsook
Khadka, Daulat Bikram
Gong, Eun-Yeung
Lee, Keesook
Cho, Won-Jea
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (08) : 3414 - 3418
[25] Discovery of thiohydantoin based antagonists of androgen receptor with efficient degradation for the treatment of prostate cancer
Chang, Xiujin
Zhang, Di
Qu, Fangui
Xie, Youquan
Chen, Tian
Zhang, Yuqing
Du, Qianming
Bian, Jinlei
Li, Zhiyu
Wang, Jubo
Xu, Xi
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
[26] Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
Obinata, Daisuke
Lawrence, Mitchell G.
Takayama, Kenichi
Choo, Nicholas
Risbridger, Gail P.
Takahashi, Satoru
Inoue, Satoshi
FRONTIERS IN ONCOLOGY, 2020, 10
[27] Androgen antagonists: Potential role in prostate cancer prevention
Trump, DL
Waldstreicher, JA
Kolvenbag, G
Wissel, PS
Neubauer, BL
UROLOGY, 2001, 57 (4A) : 64 - 67
[28] The androgen receptor and mechanisms for androgen independence in prostate cancer
Javidan, J
Deitch, AD
Shi, XB
White, RWD
CANCER INVESTIGATION, 2005, 23 (06) : 520 - 528
[29] Androgen receptor mutations in prostate cancer
Barrack, ER
MOUNT SINAI JOURNAL OF MEDICINE, 1996, 63 (5-6): : 403 - 412
[30] Androgen receptor mutations in prostate cancer
Marcelli, M
Ittmann, M
Mariani, S
Sutherland, R
Nigam, R
Murthy, L
Zhao, YL
DiConcini, D
Puxeddu, E
Esen, A
Eastham, J
Weigel, NL
Lamb, DJ
CANCER RESEARCH, 2000, 60 (04) : 944 - 949

← 1 2 3 4 5 →